Theratechnologies (THTX) News Today $1.22 +0.02 (+1.67%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Theratechnologies Inc. (NASDAQ:THTX) Short Interest Up 26.8% in OctoberTheratechnologies Inc. (NASDAQ:THTX - Get Free Report) was the target of a large growth in short interest in October. As of October 31st, there was short interest totalling 43,000 shares, a growth of 26.8% from the October 15th total of 33,900 shares. Currently, 0.2% of the shares of the stock are short sold. Based on an average daily trading volume, of 33,400 shares, the short-interest ratio is currently 1.3 days.November 15, 2024 | marketbeat.comTheratechnologies Inc. (THTX) Stock Price, News, Quote & History - Yahoo FinanceOctober 26, 2024 | finance.yahoo.comTheratechnologies Inc. (NASDAQ:THTX) Short Interest UpdateTheratechnologies Inc. (NASDAQ:THTX - Get Free Report) saw a large increase in short interest in October. As of October 15th, there was short interest totalling 33,900 shares, an increase of 226.0% from the September 30th total of 10,400 shares. Based on an average daily trading volume, of 33,400 shares, the days-to-cover ratio is currently 1.0 days. Approximately 0.2% of the company's stock are sold short.October 25, 2024 | marketbeat.comTheratechnologies IDWeek Presentations Highlight the Impact of Excess Visceral Abdominal Fat (EVAF) on Cardiovascular Disease (CVD) Risk in People with HIVOctober 17, 2024 | globenewswire.comTheratechnologies Unveils Study Design and Baseline Characteristics of PROMISE-US Trial of Ibalizumab in Heavily Treatment-Experienced People with HIV and Multidrug ResistanceOctober 17, 2024 | globenewswire.comCantor Fitzgerald Comments on Theratechnologies Inc.'s FY2024 Earnings (NASDAQ:THTX)Theratechnologies Inc. (NASDAQ:THTX - Free Report) - Analysts at Cantor Fitzgerald boosted their FY2024 earnings per share (EPS) estimates for shares of Theratechnologies in a research report issued to clients and investors on Friday, October 11th. Cantor Fitzgerald analyst L. Chen now anticipateOctober 14, 2024 | marketbeat.comTheratechnologies (NASDAQ:THTX) Issues Earnings ResultsTheratechnologies (NASDAQ:THTX - Get Free Report) issued its quarterly earnings data on Thursday. The company reported $0.06 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.03 by $0.03. During the same period in the previous year, the company posted ($0.03) earnings per share.October 11, 2024 | marketbeat.comTheratechnologies (THTX) was downgraded to a Hold Rating at JonesTradingOctober 10, 2024 | markets.businessinsider.comTheratechnologies (NASDAQ:THTX) Stock Quotes, Forecast and News SummaryOctober 10, 2024 | benzinga.comTheratechnologies Reports Strong Financial Results and Announces Positive Net Income for Third Quarter 2024October 10, 2024 | globenewswire.comTheratechnologies to Present Data at IDWeek 2024 Highlighting Advances in Treatment and Management of Complications in People with HIVOctober 9, 2024 | globenewswire.comTheratechnologies (THTX) Set to Announce Earnings on ThursdayTheratechnologies (NASDAQ:THTX) will be releasing earnings before the market opens on Thursday, October 10, Zacks reports.October 3, 2024 | marketbeat.comTheratechnologies to Announce Third Quarter 2024 Financial Results and Provide Business UpdateSeptember 26, 2024 | globenewswire.comTheratechnologies Announces a Risk of a Temporary Supply Disruption for EGRIFTA SV® in Early 2025September 17, 2024 | globenewswire.comTheratechnologies Inc. (NASDAQ:THTX) Sees Significant Increase in Short InterestTheratechnologies Inc. (NASDAQ:THTX - Get Free Report) saw a significant growth in short interest in August. As of August 31st, there was short interest totalling 13,800 shares, a growth of 81.6% from the August 15th total of 7,600 shares. Based on an average trading volume of 37,100 shares, the short-interest ratio is currently 0.4 days. Currently, 0.1% of the shares of the stock are short sold.September 13, 2024 | marketbeat.comTheratechnologies Inc.September 10, 2024 | baystreet.caTheratechnologies to Present at Upcoming Investor Conferences in SeptemberSeptember 9, 2024 | globenewswire.comShort Interest in Theratechnologies Inc. (NASDAQ:THTX) Expands By 67.9%Theratechnologies Inc. (NASDAQ:THTX - Get Free Report) was the recipient of a significant increase in short interest during the month of July. As of July 15th, there was short interest totalling 18,300 shares, an increase of 67.9% from the June 30th total of 10,900 shares. Currently, 0.1% of the company's stock are short sold. Based on an average daily volume of 34,700 shares, the days-to-cover ratio is presently 0.5 days.July 26, 2024 | marketbeat.comTheratechnologies Inc. (NASDAQ:THTX) Short Interest Down 24.8% in JuneTheratechnologies Inc. (NASDAQ:THTX - Get Free Report) was the recipient of a large drop in short interest in June. As of June 30th, there was short interest totalling 10,900 shares, a drop of 24.8% from the June 15th total of 14,500 shares. Based on an average daily trading volume, of 29,100 shares, the short-interest ratio is currently 0.4 days. Currently, 0.1% of the shares of the stock are sold short.July 13, 2024 | marketbeat.comTHTX Stock Earnings: Theratechnologies Beats EPS, Beats Revenue for Q2 2024July 10, 2024 | investorplace.comTheratechnologies Reports Financial Results and Announces Positive Net Income for Second Quarter 2024July 10, 2024 | globenewswire.comTheratechnologies to Announce Second Quarter 2024 Financial Results and Provide Business UpdateJune 26, 2024 | globenewswire.comTheratechnologies Inc. (NASDAQ:THTX) Stake Boosted by AIGH Capital Management LLCAIGH Capital Management LLC grew its stake in shares of Theratechnologies Inc. (NASDAQ:THTX - Free Report) by 362.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 3,719,302 shares of the company's stock after purchasingMay 27, 2024 | marketbeat.comTheratechnologies’ Sudocetaxel Zendusortide ASCO 2024 Presentation Demonstrates Signs of Long-Term Efficacy and Manageable Safety Profile in Patients with Solid TumorsMay 23, 2024 | finance.yahoo.comTheratechnologies' Sudocetaxel Zendusortide ASCO 2024 Presentation Demonstrates Signs of Long-Term Efficacy and Manageable Safety Profile in Patients with Solid TumorsMay 23, 2024 | globenewswire.comTheratechnologies Inc. (NASDAQ:THTX) Shares Purchased by Worth Venture Partners LLCWorth Venture Partners LLC raised its holdings in shares of Theratechnologies Inc. (NASDAQ:THTX - Free Report) by 362.5% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 906,557 shares of the cMay 20, 2024 | marketbeat.comTheratechnologies Reports on its Annual Meeting of ShareholdersMay 9, 2024 | globenewswire.comTheratechnologies to Present Long-Term Efficacy, Safety and Pharmacokinetic Data on Use of TH1902 (sudocetaxel zendusortide) in Solid Tumors at 2024 ASCO MeetingMay 2, 2024 | globenewswire.comTheratechnologies Announces Mailing of Management Proxy Circular in Connection with its Annual Meeting of ShareholdersApril 15, 2024 | globenewswire.comTheratechnologies Inc. (THTX) Q1 2024 Earnings Call TranscriptApril 11, 2024 | seekingalpha.comTheratechnologies to Present at the 2024 Bloom Burton & Co. Healthcare Investor ConferenceApril 11, 2024 | globenewswire.comTHTX Stock Earnings: Theratechnologies Beats EPS, Misses Revenue for Q1 2024April 10, 2024 | investorplace.comTheratechnologies Reports Financial Results and Provides Business Update for First Quarter 2024April 10, 2024 | globenewswire.comTheratechnologies Reports Financial Results and Provides Business Update for First Quarter 2024April 10, 2024 | globenewswire.comTheratechnologies Preclinical Data Presentation at AACR 2024 Highlights Versatility and Flexibility of SORT1+ Technology™ Oncology PlatformApril 8, 2024 | globenewswire.comTheratechnologies Appoints Elina Tea to its Board of DirectorsApril 5, 2024 | globenewswire.comTheratechnologies to Announce First Quarter 2024 Financial Results and Provide Business UpdateApril 3, 2024 | globenewswire.comTheratechnologies to Present Preclinical Data at AACR on Multiple PDCs Showcasing Potential of SORT1+Technology(TM) PlatformMarch 30, 2024 | stockhouse.comTheratechnologies to Present Preclinical Data at AACR on Multiple PDCs Showcasing Potential of SORT1+Technology™ PlatformMarch 28, 2024 | globenewswire.comTheratechnologies shifts focus, phases down preclinical researchMarch 24, 2024 | investing.comTheratechnologies Announces Update on its Preclinical Oncology Research ProgramMarch 22, 2024 | globenewswire.comTheratechnologies Appoints Jordan Zwick to its Board of DirectorsMarch 21, 2024 | globenewswire.comTheratechnologies Initiates Increased Dose Level in Phase 1 Clinical Trial of Sudocetaxel Zendusortide in Advanced Ovarian CancerMarch 21, 2024 | globenewswire.comTheratechnologies Announces the Resignation of One of Its Directors, Mr. Alain TrudeauFebruary 29, 2024 | globenewswire.comTheratechnologies Receives Refusal to File Letter for Trogarzo® Intramuscular Method of Administration sBLA from FDAFebruary 27, 2024 | globenewswire.comTheratechnologies: Fiscal Q4 Earnings SnapshotFebruary 21, 2024 | washingtonpost.comTheratechnologies Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2023 and Provides 2024 GuidanceFebruary 21, 2024 | globenewswire.comTheratechnologies Announces Publication in Frontiers in Immunology that Deepens Understanding of Sudocetaxel Zendusortide (TH1902) Molecular Mechanism of ActionFebruary 20, 2024 | globenewswire.comTheratechnologies Completes Enrollment of First Six Patients in Updated Phase 1 Clinical Trial of Sudocetaxel Zendusortide in Advanced Ovarian CancerFebruary 15, 2024 | finance.yahoo.comTheratechnologies Completes Enrollment of First Six Patients in Updated Phase 1 Clinical Trial of Sudocetaxel Zendusortide in Advanced Ovarian CancerFebruary 15, 2024 | globenewswire.com Get Theratechnologies News Delivered to You Automatically Sign up to receive the latest news and ratings for THTX and its competitors with MarketBeat's FREE daily newsletter. Email Address New Year, New Opportunity! 2 AI Stocks Under $10 Ready to Soar (Ad)As we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention. 👉 Click here to access your FREE report now! THTX Media Mentions By Week THTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. THTX News Sentiment▼1.950.46▲Average Medical News Sentiment THTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. THTX Articles This Week▼11▲THTX Articles Average Week Get Theratechnologies News Delivered to You Automatically Sign up to receive the latest news and ratings for THTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies MOLN News Today CYBN News Today MGNX News Today SOPH News Today ZNTL News Today GNFT News Today SLN News Today INBX News Today ZURA News Today EDIT News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:THTX) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Theratechnologies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Theratechnologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free THTX Stock Alerts